Replies to post #293426 on Elite Pharmaceuticals Inc (ELTP)

[Chasing]

No. It's completely different. Both were part of the latest pilot study.

Is the "Unique Novel new ADF platform” what Sequest-ox new formulation is using?

We have already filed for a patent for the new non-pharmacological platform.

We recently filed a patent for platform technology for ADF product that is not pharmacologically based.

As of the most recent CC, we had not filed for a patent onSequest modification, but we probably have filed by now.

. We resolve that issue and our patent attorney, Dr. Smith determined that this is something patentable and we will be filing a patent sometime next week.

https://seekingalpha.com/article/4182056-elite-pharmaceuticals-inc-eltp-ceo-nasrat-hakim-q4-2018-results-earnings-call-transcript?part=single